FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

1470271000168107: ascorbic acid 500 mg + ferrous sulfate 325 mg modified release tablet (medicinal product unit of use)


Status: current, Defined. Date: 30-Jun 2020. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4402031000168115 ascorbic acid 500 mg + ferrous sulfate 325 mg modified release tablet (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4402041000168112 ferrous sulfate 325 mg (iron 105 mg) + ascorbic acid 500 mg modified release tablet en Synonym Active Case sensitive Australian Medicines Terminology module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
ferrous sulfate 325 mg (iron 105 mg) + ascorbic acid 500 mg modified release tablet Is a medicinal product unit of use true Inferred relationship Some
ferrous sulfate 325 mg (iron 105 mg) + ascorbic acid 500 mg modified release tablet Is a ferrous sulfate + ascorbic acid true Inferred relationship Some
ferrous sulfate 325 mg (iron 105 mg) + ascorbic acid 500 mg modified release tablet has manufactured dose form modified release tablet true Inferred relationship Some
ferrous sulfate 325 mg (iron 105 mg) + ascorbic acid 500 mg modified release tablet has Australian BoSS ascorbic acid true Inferred relationship Some 177886973
ferrous sulfate 325 mg (iron 105 mg) + ascorbic acid 500 mg modified release tablet has intended active ingredient ascorbic acid true Inferred relationship Some 177886973
ferrous sulfate 325 mg (iron 105 mg) + ascorbic acid 500 mg modified release tablet has Australian BoSS ferrous sulfate true Inferred relationship Some 264339836
ferrous sulfate 325 mg (iron 105 mg) + ascorbic acid 500 mg modified release tablet has intended active ingredient ferrous sulfate true Inferred relationship Some 264339836
ferrous sulfate 325 mg (iron 105 mg) + ascorbic acid 500 mg modified release tablet has unit of use tablet true Inferred relationship Some 1544071477

Inbound Relationships Type Active Source Characteristic Refinability Group
Ferrovance C modified release tablet Is a True ferrous sulfate 325 mg (iron 105 mg) + ascorbic acid 500 mg modified release tablet Inferred relationship Some
ferrous sulfate 325 mg (iron 105 mg) + ascorbic acid 500 mg modified release tablet, 30 has MPUU True ferrous sulfate 325 mg (iron 105 mg) + ascorbic acid 500 mg modified release tablet Inferred relationship Some 2072480786

Reference Sets

Medicinal product unit of use reference set

Back to Start